Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law. Congress has been considering ...
A second major US pharmaceutical manufacturer announced on October 10, 2025, that it has entered into a drug pricing agreement with the Trump administration. The White House issued a fact sheet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback